MOMETASONE Spirig HC 0.05 mg/dose 3 fl 140 dos

7680676410025 CH-67641 R01AD09 12.02.3.
MOMETASONE Spirig HC 0.05 mg/dose 3 fl 140 dos
MOMETASONE Spirig HC 0.05 mg/dose 3 fl 140 dos
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6764101
CPT
-
Packaging group
3 x 140
Unit
Einzeldose(n)
Composition
mometasoni furoas 0.5 mg ut mometasoni furoas monohydricus, benzalkonii chloridum 0.2 mg, glycerolum, polysorbatum 80, cellulosum microcristallinum et carmellosum natricum, acidum citricum monohydricum, natrii citras anhydricus, aqua purificata ad suspensionem pro 1 g corresp. mometasoni furoas 50 µg pro dosi, doses pro vase 140.

Articles (1)

Mometason Spirig HC Nasenspray, Suspension
suspension
3 x 140
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/02/2026
Patient information leaflet
Français
07/02/2026
Patient information leaflet
Italien
07/02/2026
Professional SmPC
Allemand
07/02/2026
Professional SmPC
Français
07/02/2026

Detailed composition

Substance Quantity Type Category
mometasoni furoas
0.5 MG Substance Wirkstoff (Principe actif)
mometasoni furoas monohydricus
- Substance WIZUS
benzalkonii chloridum
0.2 MG Substance HBESI
glycerolum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
cellulosum microcristallinum et carmellosum natricum
- Substance HNIDK
acidum citricum monohydricum
- Substance HNIDK
natrii citras anhydricus
- Substance HNIDK
aqua purificata
- Substance HNIDK
mometasoni furoas
50.0 UG Substance Wirkstoff (Principe actif)

Reimbursement information

Public price
CHF 33.75
Specialties list
Yes
Generic
Yes
SL addition date: 01/12/2020

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
67641
Drug name
Mometason Spirig HC Nasenspray, Suspension
Galenic form
NASSS
ATC Code
R01AD09
Authorization status
Z
Dispensation category
B
First authorization
14/05/2020
Authorization expiration date
31/12/9999
IT number
12.02.3.
Domain
Human medicine
Field of application
Rhinitis, Nasenpolypen

Packaging details

Description (FR)
MOMETASONE Spirig HC 0.05 mg/dose 3 fl 140 dos
Description (DE)
MOMETASON Spirig HC 0.05 mg/Dosis 3 Fl 140 Dos
Market launch
14/05/2020
Narcotic (BTM)
No

Original drug

Nasonex, Dosier-Nasenspray
CHF 18.15
View original

Other packaging sizes

MOMETASONE Spirig HC 0.05 mg/dose fl 140 dos
140 EINZ
View
Buy us a coffee Explore the data